Associations Between ApoEε4 Carrier Status and Serum BDNF Levels—New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer’s Disease
- 2 July 2014
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 51 (3) , 1271-1277
Abstract
Insufficient neurotrophic support increases the risk for developing Alzheimer’s disease (AD). Mounting evidence has confirmed the association of brain-derived neurotrophic factor (BDNF) and apolipoprotein E (ApoE) with AD. As both BDNF and ApoE are suggested to be involved in modulating brain integrity, the present study is aiming to investigate the associations between these two factors. In this study, 110 AD patients and 120 cognitively normal controls (NC) were recruited for measurement of serum BDNF levels and ApoE genotyping. Serum BDNF levels in the AD group were significantly lower than that in the NC group, reflecting insufficient neurotrophic supply in AD patients. We further found that ApoE ε4+/− and ε4+/+ subjects had significantly lower serum BDNF levels than ε4−/− subjects in the whole cohort and the NC group, suggesting altered BDNF metabolism in ApoE ε4 carriers. Further analysis indicated possible interactions between ApoEε4 and BDNF in their co-effects on AD and mini-mental state examination (MMSE) scores. Our findings imply that the possible involvement of ApoE ε4 in BDNF metabolism might be another molecular mechanism underlying the contribution of ApoE ε4 to the development of AD.Keywords
This publication has 51 references indexed in Scilit:
- Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of DementiaPLOS ONE, 2013
- Selective Brain Gray Matter Atrophy Associated with APOE ε4 and MAPT H1 in Subjects with Mild Cognitive ImpairmentJournal of Alzheimer’s Disease, 2013
- Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence ofAPOEandTOMM40on Brain IntegrityInternational Journal of Alzheimer's Disease, 2012
- Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and BeyondNeuroMolecular Medicine, 2011
- Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with DementiaPsychiatry Investigation, 2009
- Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in ratsNeurobiology of Disease, 2008
- Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4Neurobiology of Aging, 2008
- Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disordersBiological Psychiatry, 2003
- Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s diseaseMolecular Brain Research, 2003
- A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learningNeuroscience, 2002